Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind Clinical Trial of the Use of Mirtazapine Versus Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

NCT03283488 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT03283488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03283488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind Clinical Trial of the Use of Mirtazapine Versus Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
March 26, 2019
Completion date
February 2, 2022
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia, cachexia; cancer